Population Collective Effective Dose from Nuclear Medicine procedures in Greece

Similar documents
EXPOSURE FROM DIAGNOSTIC NUCLEAR MEDICINE PROCEDURES. 14 Victor Babes Street, RO-6600, Iasi, Romania

Establishment of Dose Reference Levels for Nuclear Medicine in Sudan

PATIENT DOSES DUE TO DIAGNOSTIC NUCLEAR MEDICINE EXAMINATIONS IN LITHUANIA

Radiation Protection Dosimetry (2008), Vol. 131, No. 1, pp Advance Access publication 23 August 2008

Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey

RADIATION PROTECTION N 180

Population Dose from General X-ray and Nuclear Medicine: 2010

Variation of Occupational Doses among Subspecialties in Diagnostic Radiology. A.N. Al-Haj, C.S. Lagarde, A.M. Lobriguito

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

STUDIES OF LOW-DOSE RADIATION AND CANCER. E. Lubin

United Nations Scientific Committee on the Effects of Atomic Radiation

Dose Estimates for Nuclear Medicine Procedures: What are they? Where do they come from?

Recent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department

Tracking Doses in the Pediatric Population

Australian Per Caput Doses from Diagnostic Imaging and Nuclear Medicine

Outline. Lifetime Attributable Risk 10 mgy in 100,000 exposed persons (BEIR VII 2006) SPECT/CT and PET/CT Dosimetry

RADIATION PROTECTION N 180

The IAEA BSS and development of an international dosimetry protocol

Internal Dosimetry of Human Brain for 99m tc and 131 I Using Nuclear Imaging in Bangladesh

Diagnostic Reference Levels (DRLs)

Impact of ICRP-89 Based Models on Dose Estimates for Radiopharmaceuticals and CT Exams

Trends in examination frequency and population doses in Norway,

AN INTRODUCTION TO NUCLEAR MEDICINE

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

Measures taken by the authority. to reduce extremity doses. in nuclear medicine facilities. in Switzerland

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

Atoms for Health. Atoms for Health The. Atoms for Health - Division of Nuclear Health - Dept of Nuclear Aplications P Andreo DIR-NAHU 1

Several different radiopharmaceuticals have been used in

Regional diagnostic reference levels and collective effective doses from CT scanners in India

Personal Dosimetry in Sweden - Challenges and Developments

Further there has been shift from equipment focus to patient focus. During the last 15 years QC testing of equipment and dosimetry in phantoms

Protecting the Health of Uranium Mine Workers: The Situation from the 1930s to the Present Day

Whole-body biodistribution and radiation dosimetry estimates for the β-amyloid radioligand [ 11 C]MeS-IMPY in non-human primates

Why radiation protection matters?

The Management of Imaging Procedure Dose Nuclear Medicine Dose Indices

Ionizing Radiation Exposure of the Population of the United States. David A. Schauer Executive Director

Radiation Burden in Cardiology. A quick tour! David Sutton

Department of Nuclear Medicine with Positron Emission Tomography

Radiation Dosimetry for CT Protocols

Michael Lassmann, PhD, and S. Ted Treves, MD, for the EANM/SNMMI pediatric dosage harmonization working group*

Facing the challenges: IAEA activities to protect the patients

Health Concerns Related to Radiation Exposure. of the Female Nuclear Medicine Patient. Michael G. Stabin

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

HIP RADIOLOGY PROGRAM CODE LISTS

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Evening session 1 Stakeholder platform opportunity 18:30-20:00 IAEA International Atomic Energy Agency

Radiation related cancer risk & benefit/risk assessment for screening procedures

Amira K. Brown, Ph.D. Molecular Imaging Branch, NIMH Bldg. 1 Rm. B3-10

SPANISH INTERCOMPARISON OF APPROVED PERSONAL DOSIMETRY SERVICES USING PHOTON RADIATION BEAMS

RSC Approval of CHR Studies Involving Radiation Exposure to Human Subjects

UNSCEAR Recent and Future Programme of Work. Emil Bédi

Recent Progress in Radiation Dosimetry for Epidemiology and Radiological Protection. John Harrison ICRP Committee 2

Exposure of the Belgian Population to Ionizing Radiation

METROLOGY TO SUPPORT INNOVATION IN MOLECULAR RADIOTHERAPY. Glenn Flux

PHYTACIS. Kit for the preparation of technetium [ 99m Tc] phytate injection USER PACKAGE LEAFLET

SUGGESTED PRESCRIBED DOSAGE LIST

Nuclear medicine in renal scarring

REPORT OF THE TECHNICAL MEETING: THE NEW DOSE LIMIT FOR THE LENS OF THE EYE IMPLICATIONS AND IMPLEMENTATION VIENNA, 2-4 OCTOBER 2012

An Assessment of Organ and Effective Dose of Patients who Undertake CT Examinations in two Teaching Hospitals of Mashhad&Isfahan

Annex X of Technical Volume 4 RADIATION AND HEALTH EFFECTS AND INFERRING RADIATION RISKS FROM THE FUKUSHIMA DAIICHI ACCIDENT

Dollars and Sense: Are We Overshielding Imaging Facilities? Part 2

Patient Dose in the Diagnosis of PE

Major accidents in radiotherapy

Outline. NCRP Scientific Committee 6-2

Radiopharmaceuticals. Radionuclides in NM. Radionuclides NUCLEAR MEDICINE. Modes of radioactive decays DIAGNOSTIC THERAPY CHEMICAL COMPOUND

NCRP Overview Program Area Committee 4 Radiation Protection in Medicine

Austin Radiological Association Nuclear Medicine Procedure SPHINCTER OF ODDI STUDY (Tc-99m-Mebrofenin)

Why is CT Dose of Interest?

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE

UNSCEAR ANNEX E RADON: SOURCES TO EFFECTS ASSESSMENT FOR RADON IN HOMES AND WORKPLACES

Gastrointestinal tract

Release of Patients or Human Research Subjects Administered Radioactive Materials

The System of Radiological Protection: Is it fit for purpose?

Trends in Occupational Exposure in Malaysia

TECHNESCAN SESTAMIBI NAME OF THE MEDICINE DESCRIPTION. Kit for the preparation of Technetium [ 99m Tc] Sestamibi Injection

Nuclear Medicine and PET. D. J. McMahon rev cewood

Impact of ICRP-89 Based Models on Dose Estimates for Radiopharmaceuticals and CT Exams. Stabin MG, Kost SD, Clark JH, Pickens DR, Price RR, Carver DE

Chernobyl weapons test Global Sweden Global Sweden 2,600,000 5,300. Malignancies 225, , ICRP 60 Malignancies

CT Radiation Risks and Dose Reduction

IAEA Activities related to Nuclear Medicine

European evidence-based consensus on the use of imaging techniques in inflammatory bowel disease diagnosis and management

Radiation Dose Reconstruction and Probability of Causation for Compensation

Individualised Treatment Planning for Radionuclide therapy (Molecular Radiotherapy)

Conflict of Interest Disclosure

KEYWORDS: nuclear medicine; gamma camera; radiopharmaceutical activities.

Austin Radiological Association Nuclear Medicine Procedure WHITE BLOOD CELL MIGRATION STUDY (In-111-WBCs, Tc-99m-HMPAO-WBCs)

Attention. Therefore, all the data and statements made in this presentation are preliminary and might change in the future.

Radiation Dose Specification

Occupational radiation exposure at IRNUM, Pakistan

Quality and Safety of Patient Healthcare and Personalized Medicine Using Ionizing Radiation

Radiation Dose Rates from Patients Administrated Radiopharmaceuticals Used for Brain Blood Flow Investigation.

The ORAMED project: Optimization of Radiation Protection for Medical Staff in Interventional Radiology, Cardiology and Nuclear Medicine

Austin Radiological Association BRAIN AMYLOID STUDY (F-18-Florbetapir)

Radiation Protection Dosimetry Advance Access published April 22, 2008

Biological Effects of Radiation KJ350.

Parathyroid Imaging What is best

Conflict of Interest Disclosure

Radiation Exposure to Staff Using PET/CT Facility

CEREBRAL BLOOD FLOW AND METABOLISM

Transcription:

Population Collective Effective Dose from Nuclear Medicine procedures in Greece S.Vogiatzi, M.Lambrinakou, A.Liossis, C.J.Hourdakis Greek Atomic Energy Commission www.eeae.gr

Contents Introduction Materials & Methods Results Discussion Conclusions

Introduction legislation 2001 - first Ministerial Order - annual collection of frequencies 2003 GAEC s Board of Directors decision - annual data collection of nuclear medicine therapies (i.e. radiopharmaceutical, administered activity, hospitalization dates etc) 2007 Ministerial Order establishment of national DRLs for nuclear medicine procedures (adults) 2010 - Ministerial Order - GAEC to estimate population collective effective doses from medical applications, every 3 years 2012 collection of data for the establishment of national

Introduction the survey 2010 - the most recent national survey of NM practice in Greece - GAEC s Department of Licensing and Inspections (DLI) The objectives of this survey were: a) the assessment of different NM procedures frequencies, b) the estimation of relevant uncertainties c) the determination of annual collective effective dose to the Greek population from NM and d) the determination of relative contribution of different NM procedures.

Materials & Methods Collection of frequencies: nuclear medicine departments submit annually to GAEC the frequency data questionnaire record keeping by GAEC (database) the data used correspond to the year 2009 the 2009 survey Collection of administered activities: during on site inspections carried out by GAEC, nuclear medicine specialists fill in a questionnaire pragmatic values (MBq) for standard sized adult patients the data used in the 2009 survey 2009 survey correspond to period 2006-2009

Materials & Methods Diagnostic part of NM frequency questionnaire Pediatric NM exams not collected Examination type Thyroid scan I-131 Thyroid scan Tc-99m Renal static scan Renal dynamic scan (only DTPA) Bone scan Lung scan (only perfusion) Myocardium scan Tl-201 Myocardium scan Tc-99m MUGA Whole body scan Tl-201 Whole body scan Ga-67 Whole body scan In-111 Whole body scan I-131 Liver-spleen scan (gastro) PET Other scans Total number of scans No. of exams: mandatory, Number of exams Number of patients No. of patients: optional

Materials & Methods The collected activity data correspond to 100% of NM dep/s. The collected frequency data correspond to 86% - 100% of NM dep/s. Scaling up to 100% 46 working weeks per year Definition of 4 workload categories for each procedure The n/a nuclear medicine departments were categorized by estimating their workload based on: previous years workloads annually supplied radiopharmaceutical activities regional population density on-site inspection outcomes

Materials & Methods Scaling up to 100% (cont d) : Example: bone scan Cat. 4 0 No. of exams 100 (approx. 2 patients/week) Cat. 3 100 < No. of exams 500 (approx. 11 patients/week) Cat. 2 500 < No. of exams 1000 (approx. 22 patients/week) 50 300 750 2000 Cat. 1 1000 < No. of exams 3000 (more than 22 patients/week) The average value of frequency was assigned to the n/a nuclear medicine departments for each workload category.

Materials & Methods Scaling up to 100% - uncertainty estimation : max min Workload Category (cat): min < No. of exams max 2 δx = δx u cat = 3 Type B, rectangular distribution in each category, all n/a NM dep/s have the same u cat Frequency uncertainty 2 u = ( N u ) freq cat n / anmdeps, cat cat Relative frequency uncertainty per procedure u relfreq u freq = 100% frequency

Materials & Methods Average admin. activity (MBq) ICRP factor (msv/mbq) = Effective dose (msv) per procedure [Effective dose (msv) Frequency ] per procedure = ( ) Population effective dose per procedure (mansv) Population effective dose (mansv) from NM procedures Population effective dose (mansv) / country s population = Effective dose per caput (msv)

Results Total number of procedures: 257212 Population collective effective dose: 1.79manSv Annual per caput effective dose: 0.16mSv

Results National NM Top 5 201 Tl myocardium scan 99m Tc MIBI myocardium scan (stress and rest) 99m Tc bone scan 131 I thyroid scan (after ablation, 0% uptake) 99m Tc thyroid scan Relative standard uncertainty (k=1) for the Top 5 exams frequency extrapolation ranges from 0.8% - 3.4%.

Results The national Top 5 NM exams contribute 83% to the total NM frequency in Greece 91% to the total collective effective dose from NM procedures in Greece

Conclusions The NM practice in Greece seems to follow the global practice (UNSCEAR 2008) dominated by cardiovascular studies, bone scans and thyroid studies. Average Administered Activities (AAAs) calculated in this survey (2006-2009 data) do not exhibit remarkable changes, compared to the ones calculated in the past (2002-2005 data*). Conclusions relevant to NM frequency trends cannot be drawn - the scale-up method used in the 2009 survey was different than the one used in the past. The annual per caput effective dose of 0.16mSv from NM procedures in Greece is higher than the mean per caput (0.12mSv), corresponding to Level *Establishment I countries of (UNSCEAR Dose Reference 2008). Levels for Nuclear Medicine in Greece S.Vogiatzi, P.Kipouros and M.Chobis, Radiat. Prot. Dosimetry (2011) doi:10.1093

Thank you for your attention